Astronics Corp

ATRO is entrenched in a Stage 4 decline with key support broken and a clear lower-high/lower-low sequence under declining short‐term EMAs and the 50 DMA. Medium‐term bias is bearish, but price is now extended below the EMA cluster and oversold, so selling should be deferred. Optimal execution lies on rallies into the declining 9/21/50 EMAs and prior support zone for rejection.

• ↑2026 revenue guided at $970M–$1B, implying 14–16% YoY growth
• ↑Q1 bookings reached $290M, driving $734M backlog for future sales
• ↓Negative earnings yield underscores weak profitability capacity